BRCA hotspot mutation screening in a cancer awareness program: A pilot experience from a tertiary care center
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
In India, up to 15% of breast and ovarian cancers are genetic, and the use of PARP-inhibitors in BRCA-positive cases highlights the clinical imperative for genetic testing. However, the lack of awareness among the community and the high cost of genetic testing are the major challenges. Awareness programs in hospitals, educational institutions, and public health centers would enable implement genetic testing; and structured counselling would de-escalate patient distress, facilitate timely, evidence-based treatment or prophylactic measures. This report highlights the importance of cancer awareness programs and the utility of a cost-effective strategy for BRCA recurrent mutation screening among breast and/ovarian cancer patients.
Fields of Study & Subjects
BRCA gene mutations in cancer
PARP inhibition in cancer therapy
Breast Lesions and Carcinomas
Publication details
- Journal / source
- Indian Journal of Pathology and Oncology
- Volume
- 13
- Issue
- 1
- Pages
- 55–58
- Publication date
- 31 March 2026
- Language
- EN